Platelet Activation and Platelet–Leukocyte Aggregates in Type I Diabetes Mellitus
Authors:
Open Access
- 11 October 2018
- journal article
- research article
- Published by SAGE Publications in Clinical and Applied Thrombosis/Hemostasis
- Vol. 24 (9_suppl) , 230S-239S
Abstract
Hyperglycemia alone may not explain the increased risk of cardiovascular diseases (CVDs) in patients with type 1 diabetes (T1D) compared with type 2. This study emphases on the evaluation of some platelet activity markers in patients with T1D, with relevance to some metabolic disorders as hyperlipidemia and hyperglycemia. This study was performed on 35 patients with T1D and 20 healthy controls. All participants were subjected to full history taking, clinical examination and assay of glycated hemoglobin (HbA1c), and lipid profile. The expression of CD62P and CD36 on platelets and the frequency of platelet–monocyte, and platelet–neutrophil aggregates were assessed by flow cytometry. Patients showed significantly higher expression of CD62P and CD36 than the control group. Platelets aggregates with monocytes were also higher among patients than the control group. Levels of CD36+ platelets, CD62P+ platelets, and platelet–monocyte aggregates revealed significant correlations with the levels of HbA1c, total cholesterol, low-density lipoprotein, and triglycerides. Hyperlipidemia and hyperglycemia accompanying T1D have a stimulatory effect on platelet activation which probably makes those patients vulnerable to CVD than nondiabetics.Keywords
This publication has 38 references indexed in Scilit:
- Potential Biomarkers of Insulin Resistance and Atherosclerosis in Type 2 Diabetes Mellitus Patients with Coronary Artery DiseaseInternational Journal of Endocrinology, 2013
- The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low‐dose aspirin in patients with and without diabetesJournal of Thrombosis and Haemostasis, 2012
- Alterations of platelet biochemical and functional properties in newly diagnosed type 1 diabetes: a role in cardiovascular risk?Diabetes/Metabolism Research and Reviews, 2011
- Factors Contributing to Increased Platelet Reactivity in People With DiabetesDiabetes Care, 2009
- Oxidation by hypochlorite converts protective HDL into a potent platelet agonistFEBS Letters, 2008
- Preferential binding of platelets to monocytes over neutrophils under flowBiochemical and Biophysical Research Communications, 2005
- Multiple Metabolic Hits Converge on CD36 as Novel Mediator of Tubular Epithelial Apoptosis in Diabetic NephropathyPLOS Medicine, 2005
- Binding of Low Density Lipoprotein to Platelet Apolipoprotein E Receptor 2′ Results in Phosphorylation of p38MAPKJournal of Biological Chemistry, 2004
- Platelet HDL3 binding sites are not related to integrin αIIbβ3 (GPIIb–IIIa)Atherosclerosis, 2001
- Thromboxane Biosynthesis and Platelet Function in Type I Diabetes MellitusNew England Journal of Medicine, 1988